‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant-Reference-Cited by-同舟云学术

‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant

Published:2021-11 Issue: Volume:25 Page:100337
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Fabrizi Fabrizio,Alonso Cristina,Palazzo Ana,Anders Margarita,Reggiardo Maria Virginia,Cheinquer Hugo,Zuain Maria Grazia Videla,Figueroa Sebastian,Mendizabal Manuel,Silva Marcelo,Ridruejo Ezequiel

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference26 articles.

1. Hepatitis C and its impact on renal transplantation;Morales;Nat Rev Nephrol,2015

2. The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients;Knoll;Am J Kidney Dis,1997

3. Impact of hepatitis B and C virus on kidney transplantation outcome;Mathurin;Hepatology,1999

4. Meta-analysis of observational studies: hepatitis C and survival after renal transplant;Fabrizi;J Viral Hepat,2014

5. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease;Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group;Kidney Int Suppl,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting perspectives in liver diseases after kidney transplantation;World Journal of Hepatology;2023-07-27

2. Real-world effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C virus in kidney and liver transplant recipients: experience of a large transplant center in Brazil;Revista do Instituto de Medicina Tropical de São Paulo;2023

3. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease;Kidney International;2022-12